IL6 and chronic lung disease: However, notable exceptions included a higher prevalence of chronic lung disease in the conventional group compared to the pt-qPCR group (58.0% vs. 20.4%, P < 0.001) and a lower median IL-6 level in the conventional group (133.22 vs. 171.28, P < 0.001).